# Cost-effectiveness analysis of sunitinib in patients with metastatic and/or unresectable gastrointestinal stroma tumours (GIST) after progression or intolerance with imatinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-analysis-of-sunitinib-in-patients-with-metastatic-and-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Luis Paz‐Ares,Xavier García del Muro,Enrique Grande,Paloma González,Max Brosa,Silvia Díaz‐Cerezo |
| Citations | 27 |
| DOI | 10.1007/s12094-008-0297-3 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2142990859 |
| PMID | 19068454 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Silvia Díaz‐Cerezo](https://scholariq.org/researchers/silvia-diaz-cerezo/)

## Paper primary topic

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)

## Paper topics

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.